Clinical Trials Browser

OTHER × Interventional × monalizumab × Clear all

NCT07146230 2026-05-06

SPRINT 2

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05903092 2026-04-29

MOZART

Phase 2 Recruiting

Small Cell Lung Carcinoma

NCT06503614 2026-04-08

ENHANCE

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT06152523 2026-04-06

MONAMI

Phase 2 Withdrawn

Neoplasms

NCT06892223 2025-03-24

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

Phase 2 Recruiting

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

NCT04307329 2024-10-22

MIMOSA

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT03833440 2024-05-03

PIONeeR

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04333914 2022-09-30

IMMUNONCOVID

Phase 2 Completed

COVID-19, Infections, Neoplasms

NCT02921685 2018-09-19

PIRAT

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT03307941 2017-12-19

ARTEMIS-Eso

Phase 1/2 Withdrawn

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma